{"paper_id":"ed68c818-46f2-41c4-9ba4-a93d2c38ca23","body_text":"Publication: Primary Peritoneal Serous Borderline Tumors as a Therapeutic Challenge: a Systematic Review of the Literature\nPrimary Peritoneal Serous Borderline Tumors as a Therapeutic Challenge: a Systematic Review of the Literature\nDate\nDate\nDate\nCitations\nPape, J., Samartzis, E. P., Choschzick, M., Fink, D., & Imesch, P. (2020). Primary Peritoneal Serous Borderline Tumors as a Therapeutic Challenge: a Systematic Review of the Literature. SN Comprehensive Clinical Medicine, 2, 316–326. https://doi.org/10.1007/s42399-020-00232-0\nAbstract\nAbstract\nAbstract\nPrimary peritoneal serous borderline tumors (PPSBT) are rare neoplasms that can present as an incidental finding at laparoscopy and raise concern regarding a primary ovarian tumor with peritoneal implants. The aim is to present an overview of all reported cases of PPSBT, including a case from our own department, with a focus on clinical presentation, diagnosis, therapeutic options, and prognosis. A search for articles containing various terminologies describing PPSBT was performed via PubMed. We included English and French language pu\nMetrics\nDownloads\nViews\nAdditional indexing\nCreators (Authors)\nVolume\nVolume\nVolume\nNumber\nNumber\nNumber\nPage range/Item number\nPage range/Item number\nPage range/Item number\nPage end\nPage end\nPage end\nItem Type\nItem Type\nItem Type\nIn collections\nDewey Decimal Classifikation\nDewey Decimal Classifikation\nDewey Decimal Classifikation\nLanguage\nLanguage\nLanguage\nPublication date\nPublication date\nPublication date\nDate available\nDate available\nDate available\nISSN or e-ISSN\nISSN or e-ISSN\nISSN or e-ISSN\nOA Status\nOA Status\nOA Status\nFree Access at\nFree Access at\nFree Access at\nPublisher DOI\nMetrics\nDownloads\nViews\nCitations\nPape, J., Samartzis, E. P., Choschzick, M., Fink, D., & Imesch, P. (2020). Primary Peritoneal Serous Borderline Tumors as a Therapeutic Challenge: a Systematic Review of the Literature. SN Comprehensive Clinical Medicine, 2, 316–326. https://doi.org/10.1007/s42399-020-00232-0","source_license":"CC0","license_restricted":false}